Log In
Print this Print this

Opsumit, macitentan (formerly ACT-064992, Actelion-1)

  Manage Alerts
Collapse Summary General Information
Company Actelion Ltd.
DescriptionTissue-targeting endothelin receptor antagonist
Molecular Target Endothelin receptor
Mechanism of ActionEndothelin receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today